-
Mashup Score: 1Vascular Disease Management - 4 year(s) ago
Hollywood, FL (January 23, 2020) – In the first and only head-to-head comparison of two paclitaxel-eluting stents used in peripheral intervention, no difference was seen for the primary endpoint of primary patency at 24 months. Clinical improvements were similar and sustained in both groups.
Categories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Vascular Disease Management - 4 year(s) ago
Findings from 7 different real-world data sources show no difference in survival following treatment with drug-coated and non-drug-coated devices, according to a presentation given today at the International Symposium on Endovascular Therapy (ISET).
Categories: Cardiologists, Latest HeadlinesTweet-
In an #ISET2020 presentation by Eric Secemsky, MD, paclitaxel comes up clean in multiple real-world datasets. Read more here: https://t.co/ncCzpvDmFI https://t.co/TTFexS6wxR
-
-
Mashup Score: 0Vascular Disease Management - 4 year(s) ago
The study design of a recently published meta-analysis by Katasanos and colleagues is flawed, according to a critique presented by William Gray, MD, at the International Symposium on Endovascular Therapy (ISET).
Categories: Cardiologists, Latest HeadlinesTweet-
The study design of a recently published meta-analysis by Katasanos and colleagues is flawed, according to a critique presented by William Gray, MD, at #ISET2020. Read more here: https://t.co/mx6RAiDjCn https://t.co/ci6kKzLbSg
-
-
Mashup Score: 1Vascular Disease Management - 4 year(s) ago
Hollywood, FL (January 22, 2020) — The rapid advance of technology was the focus of a morning session on the first day of the International Symposium on Endovascular Therapy (ISET).
Categories: CardiologistsTweet-
“The use of robotics in the delivery of healthcare is growing,” Barry T. Katzen, MD, said in today's emerging technologies in endovascular therapy symposium. Read more about the session here: https://t.co/M62j0OtzOZ @ISETNews @DrBTKatzen #ISET2020 https://t.co/38lghALoK9
-
-
Mashup Score: 0Vascular Disease Management - 4 year(s) ago
Hollywood, FL (January 22, 2020) — The International Symposium on Endovascular Therapy (ISET) 2020 started its first day with a provocative and informative session on the business of healthcare.
Categories: CardiologistsTweet-
Focused Session on the Business of Healthcare Offers Pearls for Everyone, Read more here: https://t.co/iVQaiEzdKK @ISETNews #ISET2020 https://t.co/Iwew8yyODB
-
-
Mashup Score: 0Drug-Coated Balloons for Treatment of Infrapopliteal Peripheral Artery Disease: Where Do We Stand? | Vascular Disease Management - 4 year(s) ago
Serdar Farhan, MD, Haroon Kamran, MD and Prakash Krishnan, MD
Categories: CardiologistsTweet-
Krishnan et al: Drug-Coated Balloons for Treatment of Infrapopliteal Peripheral Artery Disease: Where Do We Stand? "How shall we approach patients with CLI in light of the findings of [the latest Katsanos et al] meta-analysis?" https://t.co/DswAbtMFj2 @PK_MountSinai #CLIFighters
-
-
Mashup Score: 4Commentary Regarding Katsanos et al’s Meta-Analysis: Finding a Silver Lining in the Controversy | Vascular Disease Management - 4 year(s) ago
Sahil A. Parikh, MD
Categories: CardiologistsTweet-
It is “a bit of déjà vu all over again,” writes Dr. Sahil A. Parikh, in a commentary to the new meta-analysis by Katsanos et al that focuses on paclitaxel-coated balloons in CLI below the knee. https://t.co/8SJTNyWecc @sahilparikhmd #cardiotwitter #TwittIR #CLIfighters
-
-
Mashup Score: 2Katsanos et al Publish Second Meta-Analysis, Reviewing PCBs in Treatment of CLI BTK | Vascular Disease Management - 4 year(s) ago
Meta-analysis links PCBs to increase in death and amputation
Categories: CardiologistsTweet-
Katsanos et al, 2nd Meta-Analysis Published re PCBs in Treatment of CLI BTK. *Commentaries: Beasley, Liistro, Mustapha, Zeller* https://t.co/yrSm4NYV6D #cardiotwitter #CLIFighters #TwittIR @Mustapja @FrancescoLiist1
-
-
Mashup Score: 2Katsanos et al Publish Second Meta-Analysis, Reviewing PCBs in Treatment of CLI BTK | Vascular Disease Management - 4 year(s) ago
Meta-analysis links PCBs to increase in death and amputation
Categories: CardiologistsTweet-
Katsanos et al, 2nd Meta-Analysis Published re PCBs in Treatment of CLI BTK. *Commentaries: Beasley, Liistro, Mustapha, Zeller* https://t.co/yrSm4NYV6D #cardiotwitter #CLIFighters #TwittIR @Mustapja @FrancescoLiist1
-
-
Mashup Score: 2Katsanos et al Publish Second Meta-Analysis, Reviewing PCBs in Treatment of CLI BTK | Vascular Disease Management - 4 year(s) ago
Meta-analysis links PCBs to increase in death and amputation
Categories: CardiologistsTweet-
Katsanos et al, 2nd Meta-Analysis Published re PCBs in Treatment of CLI BTK. *Commentaries: Beasley, Liistro, Mustapha, Zeller* https://t.co/yrSm4NYV6D #cardiotwitter #CLIFighters #TwittIR @Mustapja @FrancescoLiist1
-
William Gray, MD, shared data from the IMPERIAL trial during a morning Late Breaking Clinical Trials session at the #ISET2020 Read more: https://t.co/BmtWMUpaSx https://t.co/j4kLfFM3n8